Combined magnetic resonance imaging and positron emission tomography brain imaging in behavioural variant frontotemporal degeneration: Refining the clinical phenotype

Brain

Volumn 132, Issue 9, 2009, Pages 2566-2578

  Kipps, C M ^a,b   Hodges, J R ^b,c   Fryer, T D ^d   Nestor, P J ^b  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

FDG PET; Frontotemporal dementia; MRI; Picks disease; Social cognition

Indexed keywords

BIOLOGICAL MARKER; FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; BRAIN METABOLISM; BRAIN SIZE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FALSE POSITIVE RESULT; FEMALE; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL DEMENTIA; HUMAN; IMAGE ANALYSIS; MALE; METABOLIC RATE; MORPHOMETRICS; NERVE DEGENERATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE DIAGNOSIS; THREE DIMENSIONAL IMAGING; VISUAL ANALOG SCALE;

AGED; DEMENTIA; FEMALE; FRONTAL LOBE; GLUCOSE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARIETAL LOBE; PHENOTYPE; POSITRON-EMISSION TOMOGRAPHY; TEMPORAL LOBE;

EID: 71549115516     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awp077     Document Type: Article

References (58)

1. Alvarez JA, Emory E. Executive function and the frontal lobes: a meta-analytic review. Neuropsychol Rev 2006; 16: 17-42.
2. Bozeat S, Gregory CA, Lambon Ralph MA, Hodges JR. Which neurop-sychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease? J Neurol Neurosurg Psychiatry 2000; 69: 178-186.
3. Brett M, Anton J, Valabregue R, Poline J. Region of interest analysis using an SPM toolbox (abstract). Neuroimage 2002; 16: 2.
4. Broe M, Hodges JR, Schofield E, Shepherd CE, Kril JJ, Halliday GM. Staging disease severity in pathologically confirmed cases of frontotemporal dementia. Neurology 2003; 60: 1005-1011.
5. Brun A, Englund B, Gustafson L, Passant U, Mann D, Neary D, et al. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry 1994; 57: 416-418.
6. Ciarmiello A, Cannella M, Lastoria S, Simonelli M, Frati L, Rubinsztein DC, et al. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. J Nucl Med 2006; 47: 215-222.
7. Cortelli P, Perani D, Montagna P, Gallassi R, Tinuper P, Federica P, et al. Pre-symptomatic diagnosis in fatal familial insomnia: serial neuro-physiological and 18FDG-PET studies. Brain 2006; 129: 668-675.
8. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308-2314.
9. Davies RR, Kipps CM, Mitchell J, Kril JJ, Halliday GM, Hodges JR. Progression in frontotemporal dementia: identifying a benign behavioral variant by magnetic resonance imaging. Arch Neurol 2006; 63: 1627-1631.
10. Diehl J, Grimmer T, Drzezga A, Riemenschneider M, Forstl H, Kurz A. Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study. Neurobiol Aging 2004; 25: 1051-1056.
11. Diehl-Schmid J, Grimmer T, Drzezga A, Bornschein S, Riemenschneider M, Forstl H, et al. Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study. Neurobiol Aging 2007; 28: 42-50. (Pubitemid 44791637)
12. DSM-IV-TR. Diagnostic and statistical manual of mental disorders. 4th edn., Washington, DC: American Psychiatric Association; 2000.
13. Eckert T, Barnes A, Dhawan V, Frucht S, Gordon MF, Feigin AS, et al. FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage 2005; 26: 912-921.
14. Folstein MF, Folstein SE, McHugh PR. ''Mini-mental state''. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
15. Foster NL, Heidebrink JL, Clark CM, Jagust WJ, Arnold SE, Barbas NR, et al. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain 2007; 130: 2616-2635.
16. Garraux G, Salmon E, Degueldre C, Lemaire C, Laureys S, Franck G. Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia. Neuroimage 1999; 10: 149-162.
17. Grimmer T, Diehl J, Drzezga A, Forstl H, Kurz A. Region-specific decline of cerebral glucose metabolism in patients with frontotemporal dementia: a prospective 18F-FDG-PET study. Dement Geriatr Cogn Disord 2004; 18: 32-36.
18. Hodges JR, Davies R, Xuereb J, Kril J, Halliday G. Survival in fronto-temporal dementia. Neurology 2003; 61: 349-354.
19. Howard R, Rabins PV, Seeman MV, Jeste DV. Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. The International Late-Onset Schizophrenia Group. Am J Psychiatry 2000; 157: 172-178
20. ICD-10. International classification of diseases and related health problems (ICD-10). 10th edn., Geneva: World Health Organisation 1992.
21. Inagaki A, Iida A, Matsubara M, Inagaki H. Positron emission tomography and magnetic resonance imaging in spinocerebellar ataxia type 2: a study of symptomatic and asymptomatic individuals. Eur J Neurol 2005; 12: 725-728.
22. Jeong Y, Cho SS, Park JM, Kang SJ, Lee JS, Kang E, et al. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients. J Nucl Med 2005; 46: 233-239.
23. Jones CJ, Livson N, Peskin H. Longitudinal hierarchical linear modeling analyses of California Psychological Inventory data from age 33 to 75: an examination of stability and change in adult personality. J Pers Assess 2003; 80: 294-308.
24. Josephs KA, Whitwell JL, Jack CR, Parisi JE, Dickson DW. Frontotemporal lobar degeneration without lobar atrophy. Arch Neurol 2006; 63: 1632-1638.
25. Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG. The evolution and pathology of frontotemporal dementia. Brain 2005; 128: 1996-2005.
26. Kinahan PE Rogers JG. Analytic 3D image reconstruction using all detected events. IEEE Trans Nucl Sci 1989; 36: 964-968.
27. Kipps CM, Davies RR, Mitchell J, Kril JJ, Halliday GM, Hodges JR. Clinical significance of lobar atrophy in frontotemporal dementia: application of an MRI visual rating scale. Dement Geriatr Cogn Disord 2007a; 23: 334-342.
28. Kipps CM, Nestor PJ, Dawson CE, Mitchell J, Hodges JR. Measuring progression in frontotemporal dementia: implications for therapeutic interventions. Neurology 2008; 70: 2046-2052.
29. Kipps CM, Nestor PJ, Fryer TD, Hodges JR. Behavioural variant frontotemporal dementia: not all it seems? Neurocase 2007b; 13: 237-247.
30. Knopman DS, Boeve BF, Parisi JE, Dickson DW, Smith GE, Ivnik RJ, et al. Antemortem diagnosis of frontotemporal lobar degeneration. Ann Neurol 2005; 57: 480-488.
31. Kraeppelin E. Manic-depressive insanity and paranoia. Edinburgh: E. & S. Livingstone; 1921.
32. Kril JJ, Halliday GM. Clinicopathological staging of frontotemporal dementia severity: correlation with regional atrophy. Dement Geriatr Cogn Disord 2004; 17: 311-315.
33. Kril JJ, Macdonald V, Patel S, Png F, Halliday GM. Distribution of brain atrophy in behavioral variant frontotemporal dementia. J Neurol Sci 2005; 232: 83-90.
34. Malhi GS, Mitchell PB, Parker GB. Rediscovering chronic mania. Acta Psychiatr Scand 2001; 104: 153-156.
35. Masdeu JC, Zubieta JL, Arbizu J. Neuroimaging as a marker of the onset and progression of Alzheimer's disease. J Neurol Sci 2005; 236: 55-64.
36. Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, Hodges JR. A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology 2000; 55: 1613-1620.
37. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 2001; 58: 1803-1809.
38. McMurtray AM, Chen AK, Shapira JS, Chow TW, Mishkin F, Miller BL, et al. Variations in regional SPECT hypoperfusion and clinical features in frontotemporal dementia. Neurology 2006; 66: 517-522.
39. McNeill R, Sare GM, Manoharan M, Testa HJ, Mann DM, Neary D, et al. Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer's disease. J Neurol Neurosurg Psychiatry 2007; 78: 350-355.
40. Meltzer CC, Kinahan PE, Greer PJ, Nichols TE, Comtat C, Cantwell MN, et al. Comparative evaluation of MR-based partial-volume correction schemes for PET. J Nucl Med 1999; 40: 2053-2065.
41. Mendhekar DN, Srivastav PK, Jiloha RC, Awana S. Chronic but not resistant mania: a case report. Acta Psychiatr Scand 2004; 109: 147-149.
42. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997; 42: 85-94.
43. Morris JC. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr 1997; 9 (Suppl 1): 173-176.
44. Nagahama Y, Okina T, Suzuki N, Matsuda M. The Cambridge Behavioral Inventory: validation and application in a memory clinic. J Geriatr Psychiatry Neurol 2006; 19: 220-225.
45. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546-1554.
46. Nestor PJ, Caine D, Fryer TD, Clarke J, Hodges JR. The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer's disease) with FDG-PET. J Neurol Neurosurg Psychiatry 2003a; 74: 1521-1529.
47. Nestor PJ, Fryer TD, Hodges JR. Declarative memory impairments in Alzheimer's disease and semantic dementia. Neuroimage 2006; 30: 1010-1020.
48. Nestor PJ, Fryer TD, Smielewski P, Hodges JR. Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment. Ann Neurol 2003b; 54: 343-351.
49. Nestor PJ, Scheltens P, Hodges JR. Advances in the early detection of Alzheimer's disease. Nat Med 2004; 10 (Suppl): S34-41.
50. Peters F, Perani D, Herholz K, Holthoff V, Beuthien-Baumann B, Sorbi S, et al. Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia. Dement Geriatr Cogn Disord 2006; 21: 373-379.
51. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979; 6: 371-388.
52. Ravenna H, Jones C, Kwan VS. Personality change over 40 years of adulthood: hierarchical linear modeling analyses of two longitudinal samples. J Pers Soc Psychol 2002; 83: 752-766.
53. Salmon E, Garraux G, Delbeuck X, Collette F, Kalbe E, Zuendorf G, et al. Predominant ventromedial frontopolar metabolic impairment in frontotemporal dementia. Neuroimage 2003; 20: 435-440.
54. Salmon E, Kerrouche N, Herholz K, Perani D, Holthoff V, Beuthien-Baumann B, et al. Decomposition of metabolic brain clusters in the frontal variant of frontotemporal dementia. Neuroimage 2006; 30: 871-878.
55. Sato T, Bottlender R, Schroter A, Moller HJ. Psychopathology of early-onset versus late-onset schizophrenia revisited: an observation of 473 neuroleptic-naive patients before and after first-admission treatments. Schizophr Res 2004; 67: 175-183.
56. Siegler IC, Dawson DV, Welsh KA. Caregiver ratings of personality change in Alzheimer's disease patients: a replication. Psychol Aging 1994; 9: 464-466.
57. Strauss ME Pasupathi M. Primary caregivers' descriptions of Alzheimer patients' personality traits: temporal stability and sensitivity to change. Alzheimer Dis Assoc Disord 1994; 8: 166-176.
58. Terracciano A, Costa PT Jr, McCrae RR. Personality plasticity after age 30. Pers Soc Psychol Bull 2006; 32: 999-1009